Stay updated on ASP1517 Oral Dosing in Anemia: Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Oral Dosing in Anemia: Clinical Trial page.

Latest updates to the ASP1517 Oral Dosing in Anemia: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page update adds a system revision tag (Revision: v3.4.2) and removes the prior government funding/operating status notice.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding lapse notice with operating status guidance and a Revision: v3.4.1 tag. Removed the previous Revision: v3.4.0 tag.SummaryDifference0.3%

- Check28 days agoChange DetectedThe changes are minor UI/label updates on the page. They include showing the glossary, capitalization tweaks to labels related to QC criteria, the No FEAR Act wording, and a revision number bump from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check35 days agoChange DetectedAdded Kyntra Bio as a collaborator and removed FibroGen from the study's collaborator list.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page now shows an updated revision line, adding 'Revision: v3.3.4' and removing 'Revision: v3.3.3'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations section updated with a new Iwate site. The Iwate Locations entry and the HHS Vulnerability Disclosure footer link were removed.SummaryDifference0.2%

Stay in the know with updates to ASP1517 Oral Dosing in Anemia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Oral Dosing in Anemia: Clinical Trial page.